- News Home
27 November 2013 12:59 pm ,
Vol. 342 ,
The new head of the National Center for Science Education promises to "fight the good fight" against attacks on...
Analyses of the H7N9 strains isolated from four new cases show that the virus is evolving rapidly, heightening anxiety...
In 2009, Jack Szostak shared a Nobel Prize for his part in discovering the role of telomeres, the end bits of...
Science has exposed a thriving academic black market in China involving shady agencies, corrupt scientists, and...
Paper-selling agencies flourish in the aura of reputable businesses. For some scientists, it may be difficult to tell...
Data collected by satellites and floating probes have chronicled a 2-decade rise in the temperature and thickness of a...
Cholesterol, the artery-clogging molecule that contributes to cardiovascular disease, has another nasty trick up its...
Until recently, the Defense Advanced Research Projects Agency (DARPA) kept its plans for its $70 million portion of the...
- 27 November 2013 12:59 pm , Vol. 342 , #6162
- About Us
NIH Environmental Health Chief Steps Aside
20 August 2007 (All day)
In an escalating controversy, David Schwartz, director of the National Institute of Health's (NIH's) environmental health institute, is stepping aside while NIH conducts a sweeping review of the $642-million-a-year institute.
Schwartz, a pulmonologist at Duke University, took the helm of the National Institute of Environmental Health Sciences (NIEHS) in Research Triangle Park, North Carolina, in May 2005. Senator Charles Grassley (R-IA) has recently raised ethics questions about Schwartz's management practices, including his consulting work for law firms, his use of guest researchers from Duke, and cost overruns in his laboratory budget (Science, 6 July, p. 26). Lawmakers have also questioned Schwartz's management of NIEHS's journal and the use of an outside contractor by the institute's National Toxicology Program. A memo that NIH Director Elias Zerhouni e-mailed today to the directors of NIH's 27 institutes and centers cites congressional concerns and says that Schwartz "has agreed to step aside" during a review of "specific issues raised to date" and topics such as governance, grants and contracts, financial management, and NIEHS's ethics program.
Schwartz sent an e-mail to staff that called the move "personally painful" but said he is "committed to a full and comprehensive review" of NIEHS's policies. Deputy director Samuel Wilson will serve as acting director, and Schwartz will continue as chief of his own lab at another NIH institute. Zerhouni expects the review to take several months.